[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[e-drug] Two drug systems in the U.S.
- From: "Sarah Sellers" <ssellers@jhsph.edu>
- Date: Mon, 18 Oct 2004 12:29:34 -0400
E-DRUG: Two drug systems in the U.S.
------------------------------------
dear E-druggers,
Many do not realize that a two drug system already exists in the US.
Drugs provided to seniors under Medicare Part B are increasing manufactured in massive quantities outside federal oversight under the guise of pharmacy compounding. In the US Government Accountability Office's report issued last week (Appropriate dispensing fee needed for suppliers of inhalation therapy drugs GAO-05-72), the U.S. government represented that an alternative to Astra Zeneca's Pulmicort Respules is available as a powder, and that 10 out of 12 suppliers included in their investigation regularly "compound" the medications they dispense. The report actually includes non-compliant, compounded drugs in their acquisition cost estimates. There are no generic equivalents for Pulmicort Respules, and, the budesonide bulk active marketed to pharmacies for compounding is not a pharmaceutical grade chemical (see 2004 Red Book--a sourcing reference for pharmacies).
Considering this, it may be inappropriate for the US to push for developing and least developing countries' drug supplies to meet strict US standards when they are not demanding the same for drugs supplied to U.S. Medicare beneficiaries.
Sarah Sellers, PharmD MPH
ssellers@jhsph.edu
|